Myriad Genetics, Inc. (MYGN) Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO Heiner Dreismann to Its Board of Directors  
6/11/2010 10:33:28 AM

SALT LAKE CITY, June 10, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it has elected Heiner Dreismann, Ph.D. to its Board of Directors, effective immediately, increasing the size of the Company's board from seven members to eight.